← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Mesalazine currently has availability issues reported in 6 European registers: Austria, Germany, France, Greece, Ireland, Sweden.
Shortage ATC A07EC02 · also listed as: MESALAZIN · mésalazine · MESALAZINE · data refreshed 11 September 2026
As of 11 September 2026, 6 of the 9 tracked registers list current availability issues for Mesalazine, covering 8 affected product presentations. The longest-running open report was filed in Germany on 2025-11-05 and has now been open for about 10 months. Where agencies state a cause, delivery delays lead with 1 of the 2 stated-cause reports, followed by manufacturing problems with 1. The furthest expected-resolution date currently on file is 2026-11-02; the earliest is 2026-10-30. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Germany reported first (2025-11-05), with Greece following roughly 10 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Greece, Ireland, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Mesalazine is coded A07EC02 — a medicine acting on alimentary tract and metabolism — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Limited availability Pentasa retard 1 g - Granulat + 2 more productsSalofalk 500 mg Zäpfchen Salofalk 500 mg magensaftresistente Tabletten | 2025-12-23 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Claversal Micropellets 1,5 g | 2025-11-05 | 2026-10-30 | GMP Mängel Alternatives: N/A | register ↗ |
| 🇫🇷 France | Limited availability Fivasa 400 mg, comprimé enrobé gastrorésistant + 1 more productsPentasa 1 g et 2 g, granulés en sachet et Pentasa 1 g, suppositoire | — | — | Hépato-gastroentérologie | register ↗ |
| 🇬🇷 Greece | Limited availability SALOFALK REC.SUS 4G/SINGLE DOSE BT X 7 FL X 60 ML | 2026-09-04 | 2026-11-02 | GALENICA ΑΕ Καθυστέρηση παράδοσης Εναλλακτικά άλλα σκευάσματα της ίδια Alternatives: Εναλλακτικά άλλα σκευάσματα της ίδιας κατηγορίας ATC A10AB Insulins and | register ↗ |
| 🇮🇪 Ireland | Shortage Asacolon 800mg Gastro-resistant Tablets | 2026-07-20 | 2026-07-31 | Manufacturing delay Alternatives: Alternative(s) available — see the national register. | register ↗ |
| 🇸🇪 Sweden | Expected shortage Mesalazin Orion 1000 mg Enterotablett | 2026-08-17 | 2026-09-01 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Mesalazine in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | SALOFALK REC.SUS 4G/SINGLE DOSE BT X 7 FL X 60 ML | Limited availability | 2026-09-04 | 2026-11-02 | GALENICA ΑΕ Καθυστέρηση παράδοσης Εναλλακτικά άλλα σκευάσματ |
| 🇸🇪 SE | Mesalazin Orion 1000 mg Enterotablett | Expected shortage | 2026-08-17 | 2026-09-01 | |
| 🇮🇪 IE | Asacolon 800mg Gastro-resistant Tablets | Shortage | 2026-07-20 | 2026-07-31 | Manufacturing delay |
| 🇦🇹 AT | Pentasa retard 1 g - Granulat | Resolved | 2026-06-25 | — | |
| 🇦🇹 AT | Salofalk 500 mg Zäpfchen | Limited availability | 2026-02-01 | — | |
| 🇦🇹 AT | Salofalk 500 mg magensaftresistente Tabletten | Limited availability | 2025-12-23 | — | |
| 🇩🇪 DE | Claversal Micropellets 1,5 g | Shortage | 2025-11-05 | 2026-10-30 | GMP Mängel |
| 🇫🇷 FR | Fivasa 400 mg, comprimé enrobé gastrorésistant | Limited availability | — | — | Hépato-gastroentérologie |
| 🇫🇷 FR | Pentasa 1 g et 2 g, granulés en sachet et Pentasa 1 g, suppositoire | Limited availability | — | — | Hépato-gastroentérologie |
Yes. As of 11 September 2026, availability issues are reported in: Austria, Germany, France, Greece, Ireland, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-30 to 2026-11-02. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Mesalazine: BASG (Austria), BfArM (Germany), ANSM (France), EOF limited-availability list (Greece), HPRA (Ireland), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Mesalazine — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/mesalazine/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Mesalazine availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/mesalazine/">Mesalazine shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>